SAKAR HEALTHCARE 2023-24 Annual Report Analysis

Wed, 9 Oct

SAKAR HEALTHCARE has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

SAKAR HEALTHCARE Income Statement Analysis

• Operating income during the year rose 15.0% on a year-on-year (YoY) basis.
• The company's operating profit increased by 15.4% YoY during the fiscal. Operating profit margins witnessed a fall and down at 25.0% in FY24 as against 24.9% in FY23.
• Depreciation charges increased by 20.4% and finance costs increased by 27.7% YoY, respectively.
• Other income declined by 32.0% YoY.
• Net profit for the year declined by 8.5% YoY.
• Net profit margins during the year declined from 9.6% in FY23 to 7.6% in FY24.

SAKAR HEALTHCARE Income Statement 2023-24

No. of Mths Year Ending		12 Mar-23*	12 Mar-24*	% Change
Net Sales	Rs m	1,334	1,534	15.0%
Other income	Rs m	47	32	-32.0%
Total Revenues	Rs m	1,380	1,565	13.4%
Gross profit	Rs m	333	384	15.4%
Depreciation	Rs m	150	181	20.4%
Interest	Rs m	60	76	27.7%
Profit before tax	Rs m	170	159	-6.4%
Tax	Rs m	42	42	-0.1%
Profit after tax	Rs m	128	117	-8.5%
Gross profit margin	%	24.9	25.0
Effective tax rate	%	24.9	26.6
Net profit margin	%	9.6	7.6

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

SAKAR HEALTHCARE Balance Sheet Analysis

• The company's current liabilities during FY24 stood at Rs 591 million as compared to Rs 545 million in FY23, thereby witnessing an increase of 8.4%.
• Long-term debt down at Rs 550 million as compared to Rs 982 million during FY23, a fall of 44.1%.
• Current assets rose 28% and stood at Rs 716 million, while fixed assets rose 13% and stood at Rs 3 billion in FY24.
• Overall, the total assets and liabilities for FY24 stood at Rs 4 billion as against Rs 3 billion during FY23, thereby witnessing a growth of 16%.

SAKAR HEALTHCARE Balance Sheet as on March 2024

No. of Mths Year Ending		12 Mar-23*	12 Mar-24*	% Change
Networth	Rs m	1,733	2,575	48.6
Current Liabilities	Rs m	545	591	8.4
Long-term Debt	Rs m	982	550	-44.1
Total Liabilities	Rs m	3,363	3,887	15.6
Current assets	Rs m	559	716	28.1
Fixed Assets	Rs m	2,804	3,170	13.1
Total Assets	Rs m	3,363	3,887	15.6

SAKAR HEALTHCARE Cash Flow Statement Analysis

• SAKAR HEALTHCARE 's cash flow from operating activities (CFO) during FY24 stood at Rs 245 million on a YoY basis.
• Cash flow from investing activities (CFI) during FY24 stood at Rs -515 million on a YoY basis.
• Cash flow from financial activities (CFF) during FY24 stood at Rs 274 million on a YoY basis.
• Overall, net cash flows for the company during FY24 stood at Rs 4 million from the Rs 1 million net cash flows seen during FY23.

SAKAR HEALTHCARE Cash Flow Statement 2023-24

Particulars	No. of months	12	12	% Change
	Year Ending	Mar-23	Mar-24
Cash Flow from Operating Activities	Rs m	333	245	-26.6%
Cash Flow from Investing Activities	Rs m	-744	-515	-
Cash Flow from Financing Activities	Rs m	411	274	-33.2%
Net Cash Flow	Rs m	1	4	481.3%

Current Valuations for SAKAR HEALTHCARE

• The trailing twelve-month earnings per share (EPS) of the company stands at Rs 5.4, an decline from the EPS of Rs 6.7 recorded last year.
• The price to earnings (P/E) ratio, at the current price of Rs 315.7, stands at 61.1 times its trailing twelve months earnings.
• The price to book value (P/BV) ratio at current price levels stands at 2.7 times, while the price to sales ratio stands at 4.5 times.
• The company's price to cash flow (P/CF) ratio stood at 24.7 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending		12 Mar-23*	12 Mar-24*
Sales per share (Unadj.)	Rs	70.0	70.5
TTM Earnings per share	Rs	6.7	5.4
Diluted earnings per share	Rs	5.9	5.4
Price to Cash Flow	x	0.0	24.7
TTM P/E ratio	x	0.0	61.1
Price / Book Value ratio	x	2.2	2.9
Market Cap	Rs m	3,873	7,351
Dividends per share (Unadj.)	Rs	0.0	0.0

Ratio Analysis for SAKAR HEALTHCARE

• Solvency Ratios

Current Ratio: The company's current ratio improved and stood at 1.2x during FY24, from 1.0x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 3.1x during FY24, from 3.8x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

• Profitability Ratios

Return on Equity (ROE): The ROE for the company declined and down at 4.5% during FY24, from 7.4% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

Return on Capital Employed (ROCE): The ROCE for the company declined and down at 7.5% during FY24, from 8.5% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

Return on Assets (ROA): The ROA of the company declined and down at 5.0% during FY24, from 5.6% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending		12 Mar-23*	12 Mar-24*
Current ratio	x	1.0	1.2
Debtors’ Days	Days	604	498
Interest coverage	x	3.8	3.1
Debt to equity ratio	x	0.6	0.2
Return on assets	%	5.6	5.0
Return on equity	%	7.4	4.5
Return on capital employed	%	8.5	7.5

To see how SAKAR HEALTHCARE has performed over the last 5 years, please visit here.

SAKAR HEALTHCARE Share Price Performance

Over the last one year, SAKAR HEALTHCARE share price has moved down from Rs 0.0 to Rs 0.0, registering a loss of Rs 0.0 or around 0.0%.

Overall, the NIFTY 50 is up 0.4% over the year.

(To know more, check out historical annual results for SAKAR HEALTHCARE and quarterly results for SAKAR HEALTHCARE )